Applications: SuperTab® 11SD offers the best compactability of all grades of lactose, and it is well suited to direct compression applications. Due to the low moisture content, it is used in the formulations containing moisture sensitive drugs.

Ingredient(s): Anhydrous Lactose

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle size- D10-15 ?m, D50- 170 ?m, D90- 340 ?m; Hausner ratio-1,25

Applications: Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.

Ingredient(s): Microcrystalline Cellulose

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42

Applications: Dry binder & fast disintegrant, suitable for small tablets and ODTs, providing pleasant mouthfeel due to finer particles.

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Ingredient(s): Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Solubilizer

Ingredient(s): Polysorbate 80

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Solubilizer in powder form; EXCiPACT

Applications: Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

Ingredient(s): Stearic Acid

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Solubilizer

Ingredient(s): Polyoxyl 40 hydrogenated castor oil

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Solubilizer in powder form; EXCiPACT

Applications: Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Povidone

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Capsule Filling, Direct Compression, Binding, Disintegration

Ingredient(s): Native & Pregelatinized Corn Starch

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: EXCiPACT

Applications: Maximum disintegration

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Lauryl Sulfate

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Vinylpyrrolidone-Vinyl Acetate

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Vinylpyrrolidone-Vinyl Acetate Copolymer

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Microprilled Poloxamer

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Microprilled Poloxamer

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Carbopol® 71G NF polymer is widely used in oral solid dose applications.The unique feature of this polymer is its granular form due to which it is used in direct compression formulations. The residual solvent in Carbopol 71G NF is Ethyl acetate.

Ingredient(s): Carbomer Homopolymer Type A

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Viscosity, cP (0.5 wt% at pH 7.5) - 4,000 - 11,000

Applications: Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.

Ingredient(s): Microcrystalline Cellulose

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

Ingredient(s): Microcrystalline Cellulose

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Not Available

Applications: Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.

Ingredient(s): Mannitol

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Available in different particle size as 25.µ, 50.µ, 180.µ

Applications: Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

Ingredient(s): Lactose Monohydrate

Dosage Form: Tablet

Category: Direct Compression

Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m